|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4475196A
(en)
|
1981-03-06 |
1984-10-02 |
Zor Clair G |
Instrument for locating faults in aircraft passenger reading light and attendant call control system
|
|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4486194A
(en)
|
1983-06-08 |
1984-12-04 |
James Ferrara |
Therapeutic device for administering medicaments through the skin
|
|
JPS6081397A
(ja)
|
1983-10-06 |
1985-05-09 |
荒川化学工業株式会社 |
中性抄紙方法
|
|
US4494880A
(en)
|
1984-03-14 |
1985-01-22 |
Su Wen Kuang |
Foldable clock dial
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
EP0216846B2
(en)
|
1985-04-01 |
1995-04-26 |
Celltech Limited |
Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
|
|
NZ215865A
(en)
|
1985-04-22 |
1988-10-28 |
Commw Serum Lab Commission |
Method of determining the active site of a receptor-binding analogue
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
HU196394B
(en)
|
1986-06-27 |
1988-11-28 |
Richter Gedeon Vegyeszet |
Process for preparing 2-halogenated ergoline derivatives
|
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・２・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
SE461013B
(sv)
|
1988-02-11 |
1989-12-18 |
Christian Wesslau |
Farmaceutisk komposition verksam mot lungobstruktioner bestaaende av en betaadrenerg antagonist och ett tyroideahormon
|
|
GB8809129D0
(en)
|
1988-04-18 |
1988-05-18 |
Celltech Ltd |
Recombinant dna methods vectors and host cells
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5272263A
(en)
|
1989-04-28 |
1993-12-21 |
Biogen, Inc. |
DNA sequences encoding vascular cell adhesion molecules (VCAMS)
|
|
US5217870A
(en)
|
1989-04-28 |
1993-06-08 |
Biogen, Inc. |
Monoclonal antibodies against CDX
|
|
US6307025B1
(en)
|
1989-04-28 |
2001-10-23 |
Biogen, Inc. |
VCAM fusion proteins and DNA coding therefor
|
|
US5260210A
(en)
|
1989-09-27 |
1993-11-09 |
Rubin Lee L |
Blood-brain barrier model
|
|
US6033665A
(en)
|
1989-09-27 |
2000-03-07 |
Elan Pharmaceuticals, Inc. |
Compositions and methods for modulating leukocyte adhesion to brain endothelial cells
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
US5192746A
(en)
|
1990-07-09 |
1993-03-09 |
Tanabe Seiyaku Co., Ltd. |
Cyclic cell adhesion modulation compounds
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
GB9019812D0
(en)
|
1990-09-11 |
1990-10-24 |
Scotgen Ltd |
Novel antibodies for treatment and prevention of infection in animals and man
|
|
EP1400536A1
(en)
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Method for making humanized antibodies
|
|
DK0626861T4
(da)
|
1992-01-13 |
2004-08-16 |
Biogen Inc |
Behandling af astma.
|
|
US5871734A
(en)
|
1992-01-13 |
1999-02-16 |
Biogen, Inc. |
Treatment for asthma with VLA-4 blocking agents
|
|
US5932214A
(en)
|
1994-08-11 |
1999-08-03 |
Biogen, Inc. |
Treatment for inflammatory bowel disease with VLA-4 blockers
|
|
JPH07506566A
(ja)
|
1992-02-12 |
1995-07-20 |
バイオゲン インコーポレイテッド |
炎症性胃腸病の処置
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
DE69309487T2
(de)
|
1992-11-13 |
1997-10-23 |
Univ Washington |
Peripheralisierung hämatopoietischer stammzellen
|
|
DE69419721T2
(de)
|
1993-01-12 |
2000-04-27 |
Biogen, Inc. |
Rekombinante anti-vla4 antikörpermoleküle
|
|
AU6169894A
(en)
|
1993-02-08 |
1994-08-29 |
Syntex-Synergen Neuroscience Joint Venture, The |
Methods for treating amyotrophic lateral sclerosis with cntf
|
|
ATE161730T1
(de)
|
1993-02-09 |
1998-01-15 |
Biogen Inc |
Antikörper zur behandlung von insulinabhängigen diabetes
|
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
|
US6432404B1
(en)
|
1993-12-23 |
2002-08-13 |
Icos Corporation |
Methods of inhibiting locomotor damage following spinal cord injury with α D-specific antibodies
|
|
US5840299A
(en)
*
|
1994-01-25 |
1998-11-24 |
Athena Neurosciences, Inc. |
Humanized antibodies against leukocyte adhesion molecule VLA-4
|
|
HU220799B1
(hu)
|
1994-01-25 |
2002-05-28 |
Elan Pharmaceuticals, Inc. |
Humanizált antitestek VLA-4 leukocita adhéziós molekula ellen
|
|
US5672622A
(en)
|
1994-04-21 |
1997-09-30 |
Berlex Laboratories, Inc. |
Treatment of multiple sclerosis
|
|
SE504751C2
(sv)
|
1994-06-30 |
1997-04-21 |
Lars Fredriksson |
Kopplingslänk
|
|
US5498156A
(en)
|
1994-09-02 |
1996-03-12 |
Ipsco Enterprises Inc. |
Dual-purpose guide and drum cleaner for Steckel mill coiler furnace
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
DE19541844C1
(de)
|
1995-11-09 |
1997-07-24 |
Gsf Forschungszentrum Umwelt |
Verfahren zur Herstellung von menschlichen Antikörpern und deren Verwendung
|
|
MX336813B
(es)
|
1996-02-09 |
2016-02-02 |
Abbvie Biotechnology Ltd |
Anticuerpos humanos que ligan el tnfa humano.
|
|
NZ333904A
(en)
|
1996-07-25 |
2000-06-23 |
Biogen Inc |
VLA-4 and IIb/IIIa cell adhesion inhibitors
|
|
US7361331B2
(en)
|
1996-10-18 |
2008-04-22 |
Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food |
Plant bioreactors
|
|
CA2722378C
(en)
|
1996-12-03 |
2015-02-03 |
Amgen Fremont Inc. |
Human antibodies that bind tnf.alpha.
|
|
US6890526B2
(en)
|
1997-05-06 |
2005-05-10 |
Vanderbilt University |
Methods and reagents for the treatment of multiple sclerosis
|
|
WO1999006436A1
(en)
|
1997-07-31 |
1999-02-11 |
Elan Pharmaceuticals, Inc. |
Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4
|
|
US6153653A
(en)
|
1997-11-26 |
2000-11-28 |
Protarga, Inc. |
Choline compositions and uses thereof
|
|
AU2203199A
(en)
|
1997-12-30 |
1999-07-19 |
Bioabsorbable Concepts, Inc. |
Tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases of nervous system
|
|
NZ509199A
(en)
|
1998-05-28 |
2003-10-31 |
Biogen Inc |
A VLA-4 inhibitor: oMePUPA-V
|
|
US7232830B2
(en)
|
1998-06-26 |
2007-06-19 |
Elaine A Delack |
Method for treatment of neurodegenerative diseases and effects of aging
|
|
JP2002524529A
(ja)
*
|
1998-09-14 |
2002-08-06 |
ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム |
インテグリンアンタゴニストを用いて多発性骨髄腫および骨髄腫誘導骨吸収を治療する方法
|
|
US6355623B2
(en)
|
1998-09-24 |
2002-03-12 |
Hopital-Sainte-Justine |
Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage
|
|
DE19853487A1
(de)
|
1998-11-19 |
2000-05-25 |
Fumapharm Ag Muri |
Verwendung von Dialkylfumaraten
|
|
EP1119368A2
(en)
|
1999-03-03 |
2001-08-01 |
Biogen, Inc. |
Methods of modulating lipid metabolism and storage
|
|
WO2001045725A2
(en)
|
1999-12-23 |
2001-06-28 |
Ancile Pharmaceuticals, Inc. |
Treatment for inflammatory bowel disease (ibd) and related conditions
|
|
EP1252143A1
(en)
|
2000-01-27 |
2002-10-30 |
American Cyanamid Company |
Method for preparing alpha-sulfonyl hydroxamic acid derivatives
|
|
WO2001075078A1
(en)
|
2000-03-31 |
2001-10-11 |
The Scripps Research Institute |
HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
|
|
US8288322B2
(en)
|
2000-04-17 |
2012-10-16 |
Dyax Corp. |
Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
|
|
US6537243B1
(en)
|
2000-10-12 |
2003-03-25 |
Abbott Laboratories |
Device and method for obtaining interstitial fluid from a patient for diagnostic tests
|
|
JP2004536819A
(ja)
|
2001-06-11 |
2004-12-09 |
トランジション・セラピューティックス・インコーポレーテッド |
ウイルス性、増殖性および炎症性の疾患の治療のためにビタミンｂ１２および治療薬を用いた複合治療
|
|
DK2224012T3
(da)
|
2001-12-17 |
2013-05-13 |
Corixa Corp |
Sammensætninger og fremgangsmåder til terapi og diagnose af inflammatoriske tarmsygdomme
|
|
US20040203031A1
(en)
|
2002-04-03 |
2004-10-14 |
University Of Pennsylvania |
Methods for determining drug responsiveness
|
|
WO2003070171A2
(en)
|
2002-02-15 |
2003-08-28 |
Cornell Research Foundation, Inc. |
Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
|
|
DK1485127T3
(da)
|
2002-02-25 |
2011-10-03 |
Elan Pharm Inc |
Anvendelse af midler til behandling af inflammation
|
|
AU2003217912A1
(en)
*
|
2002-03-01 |
2003-09-16 |
Xencor |
Antibody optimization
|
|
EP1553975B8
(en)
|
2002-09-27 |
2023-04-12 |
Xencor, Inc. |
Optimized fc variants and methods for their generation
|
|
WO2004035086A2
(en)
|
2002-10-16 |
2004-04-29 |
Hunter Samuel F |
Method for treatment of demyelinating central nervous system disease using gm-csf
|
|
AU2003284427A1
(en)
|
2002-11-22 |
2004-06-18 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody against lesion tissue
|
|
CA2514117A1
(en)
|
2003-01-24 |
2004-08-12 |
Elan Pharmaceuticals, Inc. |
Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
|
|
DK2236154T3
(en)
|
2003-02-10 |
2018-06-25 |
Biogen Ma Inc |
IMMUNOGLOBULIN INFORMATION AND METHOD OF PREPARING IT
|
|
US20050074443A1
(en)
|
2003-10-03 |
2005-04-07 |
Treadwell Benjamin V. |
Methods of attenuating autoimmune disease and compositions useful therefor
|
|
WO2005047327A2
(en)
|
2003-11-12 |
2005-05-26 |
Biogen Idec Ma Inc. |
NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO
|
|
WO2005063815A2
(en)
|
2003-11-12 |
2005-07-14 |
Biogen Idec Ma Inc. |
Fcϝ receptor-binding polypeptide variants and methods related thereto
|
|
MY162179A
(en)
|
2004-04-01 |
2017-05-31 |
Elan Pharm Inc |
Steroid sparing agents and methods of using same
|
|
CA2563432A1
(en)
|
2004-04-16 |
2005-12-01 |
Genentech, Inc. |
Method for augmenting b cell depletion
|
|
CA2478458A1
(en)
|
2004-08-20 |
2006-02-20 |
Michael Panzara |
Treatment of pediatric multiple sclerosis
|
|
WO2006026759A2
(en)
|
2004-09-03 |
2006-03-09 |
Genentech, Inc. |
Humanized anti-beta7 antagonists and uses therefor
|
|
CA2587597A1
(en)
|
2004-11-19 |
2006-05-26 |
Biogen Idec Ma Inc. |
Treatment for multiple sclerosis
|
|
NZ581497A
(en)
*
|
2004-12-03 |
2012-07-27 |
Biogen Idec Inc |
Delaying or preventing onset of multiple sclerosis by vla-4 ginding antibody
|
|
CA2600929A1
(en)
*
|
2005-03-04 |
2006-09-14 |
Biogen Idec Ma Inc. |
Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
|
|
EA013080B1
(ru)
|
2005-06-09 |
2010-02-26 |
Юсб Фарма С.А. |
2,6-хинолинильные производные, способы их получения и их применение
|
|
WO2007008943A2
(en)
|
2005-07-08 |
2007-01-18 |
Xencor, Inc. |
Optimized anti-ep-cam antibodies
|
|
PL2034830T3
(pl)
|
2006-05-25 |
2015-04-30 |
Biogen Ma Inc |
Przeciwciało anty-VLA-1 do leczenia udaru
|
|
WO2008021954A2
(en)
|
2006-08-09 |
2008-02-21 |
Biogen Idec Ma Inc. |
Method for distribution of a drug
|
|
US8771689B2
(en)
|
2006-12-11 |
2014-07-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Alpha B-crystallin as a therapy for ischemia or inflammation
|
|
US8931218B2
(en)
|
2007-04-19 |
2015-01-13 |
Oldcastle Building Products, Inc. |
Modular brick or block outdoor structures
|
|
EP2158318A2
(en)
|
2007-05-14 |
2010-03-03 |
Biogen Idec MA, Inc. |
Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
|
|
NZ595526A
(en)
|
2007-06-14 |
2013-03-28 |
Biogen Idec Inc |
Pharmaceutical composition comprising a vla-4 binding antibody, a phosphate buffer and a surfactant
|
|
US20090004189A1
(en)
|
2007-06-18 |
2009-01-01 |
Genentech, Inc. |
Biological markers predictive of rheumatoid arthritis response to b-cell antagonists
|
|
DE102007049542A1
(de)
|
2007-10-16 |
2009-04-23 |
Neue Magnetodyn Gmbh |
Implantierbare Vorrichtung, System zum Erzeugen lokalisierter elektromagnetischer Felder im Bereich eines Implantats und Spulenanordnung
|
|
EP2050462A1
(en)
|
2007-10-18 |
2009-04-22 |
PAION Deutschland GmbH |
Improved treatment of stroke patients
|
|
HRP20171045T1
(hr)
*
|
2010-04-16 |
2017-10-06 |
Biogen Ma Inc. |
Protutijela anti-vla-4
|
|
MX2014004025A
(es)
|
2011-10-17 |
2014-08-01 |
Univ Muenster Wilhelms |
Metodos de valoracion de riesgo de lmp y aparatos relacionados.
|
|
CN119080931A
(zh)
*
|
2018-06-04 |
2024-12-06 |
马萨诸塞州渤健公司 |
具有降低的效应功能的抗vla-4抗体
|